cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Sana Biotechnology Inc
11 own
6 watching
Current Price
$7.61
$-0.12
(-1.55%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
878.07M
52-Week High
52-Week High
12.00000
52-Week Low
52-Week Low
2.74500
Average Volume
Average Volume
3.38M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization878.07M
icon52-Week High12.00000
icon52-Week Low2.74500
iconAverage Volume3.38M
iconDividend Yield--
iconP/E Ratio--
What does the Sana Biotechnology Inc do?
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others. Its product candidates include SG295 and SG242 that target CD19+ cancer cells, including non-Hodgkin Lymphoma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia; SG221 and SG239 for the treatment of multiple myeloma; and SG328 for ornithine transcarbamylase deficiency. It also develops SG418 for sickle cell disease and beta-thalassemia; SC291, a CD19 allogeneic T cell therapy; SC255 for multiple myeloma; SC451 for type I diabetes mellitus; and SC379 for secondary progressive multiple sclerosis, Pelizaeus-Merzbacher disease, and Huntington s disease. Sana Biotechnology, Inc. was formerly known as FD Therapeutics, Inc. and changed its name to Sana Biotechnology, Inc. in September 2018. The company was incorporated in 2018 and is headquartered in Seattle, Washington.
Read More
How much money does Sana Biotechnology Inc make?
News & Events about Sana Biotechnology Inc.
Globe Newswire
10 months ago
Hypoimmune (HIP)-modified CD19-directed CAR T cells have the potential to serve as a universal off-the-shelf therapy that provides long-term durability of response without immunosuppression HIP-modified primary pancreatic islet cells alleviate diabetes in humanized mice and avoid immune rejection ...
Globe Newswire
1 year ago
Hypoimmune-modified allogeneic CD19-directed CAR T cells can evade immune detection and kill tumor cells in a novel humanized allogeneic preclinical model in vivo, including following tumor cell reinjection Findings suggest that hypoimmune-modified allogeneic CAR T cell therapeutics might overcome ...
Globe Newswire
1 year ago
SEATTLE, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, today announcedthat six abstracts have been accepted for presentation, including two oral presentations, at the 64th American Society of ...
PR Newswire
1 year ago
Alltrna Appoints Caroline Khrer, Ph.D., Vice President, Discovery Platform Alltrna Appoints Caroline Khrer, Ph.D., Vice President, Discovery Platform PR Newswire CAMBRIDGE, Mass., Oct. 17, 2022 Dr. Khrer has more than 25 years of RNA research and development experience, including pioneering novel...
Globe Newswire
1 year ago
First demonstration of the survival of allogeneic islet cells, cardiomyocytes, and retinal pigment epithelium cells transplanted into an immunocompetent non-human primate model without any immune suppression The islet autoimmune data suggest that cells with hypoimmune (HIP) edits evade allogeneic ...
Frequently Asked Questions
Frequently Asked Questions
What is Sana Biotechnology Inc share price today?
plus_minus_icon
Can Indians buy Sana Biotechnology Inc shares?
plus_minus_icon
How can I buy Sana Biotechnology Inc shares from India?
plus_minus_icon
Can Fractional shares of Sana Biotechnology Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Sana Biotechnology Inc stocks?
plus_minus_icon
What is today’s traded volume of Sana Biotechnology Inc?
plus_minus_icon
What is today’s market capitalisation of Sana Biotechnology Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Sana Biotechnology Inc?
plus_minus_icon
What percentage is Sana Biotechnology Inc down from its 52-Week High?
plus_minus_icon
What percentage is Sana Biotechnology Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$7.61
$-0.12
(-1.55%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00